EchoNous vs Infervision

EchoNous states a price and Infervision does not. The vendor says Kosmos Plus costs less than $20k, with the final quote set by configuration and location. Infervision's site lists only a contact email for pricing.

The money buys a handheld probe for a clinician at the bedside. An oncology clinic checking ejection fraction during chemotherapy fits, and a 2024 Eur Heart J Digit Health paper looked at oncology staff doing that with AI assistance. The radiology department reading CT is the Infervision buyer, and the two buyers do not overlap. Its FDA record covers InferRead Lung CT.AI for lung nodules, CT Stroke.AI for head-CT triage, and the InferOperate and InferCare planning and RECIST tools. InferRead DR Chest, its chest X-ray product, has no 510(k) in openFDA under the Infervision applicant names. A 2025 PLOS Global Public Health evaluation of that tool for TB screening in Lusaka, by independent academic authors, reported sensitivity of 90.3% and specificity of 39.2% at a cut-off of 0.12.